Ning Kong

Ning Kong

Auto-generated profile, based on publicly available information

Ning Kong

The First School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
FZFeini Zhou
Feini Zhou
HJHao Jiang
Hao Jiang
NKNing Kong
Ning Kong
JLJiangnan Lin
Jiangnan Lin
FZFan Zhang
Fan Zhang
MXMaosheng Xu
Maosheng Xu
This study was designed to explore the potential mechanisms of electroacupuncture (EA) in treating inflammatory bowel disease‐ (IBD‐) related anxiety and mood disorders. A colitis model was induced in rats with 2, 4, 6‐trinitrohydrosulfonic acid (TNBS), followed by ST36 and SP6 targeted therapy by EA or sham EA treatment. The elevated plus maze (EPM) and open‐field test (OFT) were performed to assess the state of anxiety and depression‐like behavior. Tests were carried out by 16S rDNA amplification sequence, 1H nuclear magnetic resonance (1H NMR) spectroscopy, immunofluorescence staining, and enzyme‐linked immunosorbent assay (ELISA). The analyses detailed metabolic alterations and the Toll‐like receptor 4 (TLR4) signaling pathway/NOD‐like receptor protein 3 (NLRP3) inflammasome in rats’ hippocampal region. Furthermore, the activity of the hypothalamic‐pituitary adrenal (HPA) axis and gut microbiome was assessed. As a result of treatment, EA significantly improved in the behavioral tests and altered the composition of the gut microbiome through a significant increase in the density of short chain fatty acids (SCFAs) producers mainly including Ruminococcaceae, Phascolarctobacterium, and Akkermansiaceae. EA upregulated the metabolites of the hippocampus mainly containing l‐glutamine and gamma‐aminobutyric acid (GABA), as well as ZO‐1 expression. Whereas the treatment blocked the TLR4/nuclear factor‐ kappa B (NF‐κB) signaling pathways and NLRP3 inflammasomes, along with downregulating the interleukin‐ (IL‐) 1β level. The hyperactivity of the HPA axis was also diminished. In conclusion, EA at ST36 and SP6 attenuated anxiety and depression‐like behavior in colitis model rats through their effects on the gut microbiome by modulating the hippocampal inflammatory response and metabolic disorders, as well as the HPA axis. This study provides evidence for clinical application of EA to serve as an adjunctive treatment for IBD‐related anxiety and depression.

19 January 2023 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
HJHao Jiang
Hao Jiang
RLRongrong Li
Rongrong Li
FZFan Zhang
Fan Zhang
FZFeini Zhou
Feini Zhou
JLJiangnan Lin
Jiangnan Lin
MXMaosheng Xu
Maosheng Xu
Visceral pain caused by inflammatory bowel disease (IBD) greatly diminishes the quality of life in affected patients. Yet, the mechanism of how IBD causes visceral pain is currently not fully understood. Previous studies have suggested that the central nervous system (CNS) and gut-brain axis (GBA) play an important role in IBD-inducing visceral pain. As one of the treatments for IBD, electroacupuncture (EA) has been used to treat various types of pain and gastrointestinal diseases in clinical practice. However, whether EA relieves the visceral pain of IBD through the gut-brain axis has not been confirmed. To verify the relationship between visceral pain and CNS, the following experiments were conducted. 1H-NMR analysis was performed on the prefrontal cortex (PFC) tissue obtained from IBD rat models to determine the link between the metabolites and their role in EA treatment against visceral pain. Western blot assay was employed for detecting the contents of glutamate transporter excitatory amino acid transporters 2 (EAAT2) and the glutamate receptor N-methyl-D-aspartate (NMDA) to verify whether EA treatment can alleviate neurotoxic symptoms induced by abnormal increases of glutamate. Study results showed that the glutamate content was significantly increased in the PFC of TNBS-induced IBD rats. This change was reversed after EA treatment. This process was associated with increased EAAT2 expression and decreased expression of NMDA receptors in the PFC. In addition, an increase in intestinal glutamic-metabolizing bacteria was observed. In conclusion, this study suggests that EA treatment can relieve visceral pain by reducing glutamine toxicity in the PFC, and serves an alternative clinical utility.

1 July 2021 in Radiology
Verified
Journal Article
Closed access
CGChen Gao
Chen Gao
LWLinyu Wu
Linyu Wu
NKNing Kong
Ning Kong
MXMaosheng Xu
Maosheng Xu